Elanco Animal Health shares rose nearly 8% after the company reported third-quarter earnings above expectations and raised its full-year outlook. Jeff Simmons, Elanco’s President and CEO, called it a high-quality quarter, citing 11% reported growth and broad strength across markets and product lines. He speaks with Romaine Bostick & Kailey Leinz on "The Close." (Source: Bloomberg)
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.